Carregant...
Matched cohort study on the efficacy of tocilizumab in patients with COVID-19
BACKGROUND: Tocilizumab has been proposed as a treatment for the new disease COVID-19, however, there is not enough scientific evidence to support this treatment. The objective of this study is to analyze whether the use of tocilizumab is associated with respiratory improvement and a shorter time to...
Guardat en:
| Publicat a: | One Health |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7784546/ https://ncbi.nlm.nih.gov/pubmed/33426262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.onehlt.2021.100214 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|